Condition

Sickling Disorder Due to Hemoglobin S clinical trials and research

• 2Clinical trials
• 3Countries

All recruiting trials (2)

• 131I-apamistamab conditioning for stem cell transplant in advanced sickle cell disease

  This trial tries to see if a targeted radioactive antibody (131I-apamistamab) can be used as the pre-transplant conditioning to prepare people aged 12–50 with advanced sickle cell disease and an HLA-matched sibling donor for an allogeneic stem cell transplant.

  Recruiting Phase 1 Columbia University · New York, New York · NCT07015684

• Haploidentical stem cell transplantation for sickle cell disease

  This study is testing a new type of stem cell transplant for people with sickle cell disease to see if it can cure the disease while causing fewer complications.

  Recruiting at 4 sites Phase 2 University of Regensburg · Vienna and 8 other locations · NCT04201210

Related topics

Quick answers

How many Sickling Disorder Due to Hemoglobin S clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in Austria (1 trial), Germany (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →